LaMont Barlow
VA NY Harbor Healthcare System(US)NYU Langone Health(US)
Publications by Year
Research Areas
Bladder and Urothelial Cancer Treatments, Urinary and Genital Oncology Studies, Epigenetics and DNA Methylation, Renal cell carcinoma treatment, Prostate Cancer Treatment and Research
Most-Cited Works
- → Single luminal epithelial progenitors can generate prostate organoids in culture(2014)351 cited
- → The Role of Gut Microbiome in the Pathogenesis of Prostate Cancer: A Prospective, Pilot Study(2017)216 cited
- → Long-Term Survival Outcomes with Intravesical Docetaxel for Recurrent Nonmuscle Invasive Bladder Cancer After Previous Bacillus Calmette-Guérin Therapy(2012)121 cited
- → Predicting renal functional outcomes after surgery for renal cortical tumours: a multifactorial analysis(2009)98 cited
- → Phase II Trial of Intravesical Nanoparticle Albumin Bound Paclitaxel for the Treatment of Nonmuscle Invasive Urothelial Carcinoma of the Bladder after bacillus Calmette-Guérin Treatment Failure(2014)85 cited
- → A Phase I Trial of Intravesical Nanoparticle Albumin-Bound Paclitaxel in the Treatment of Bacillus Calmette-Guérin Refractory Nonmuscle Invasive Bladder Cancer(2011)79 cited
- → Serum tumor markers in the evaluation of male germ cell tumors(2010)75 cited
- → Long-term Clinical Outcomes of a Phase I Trial of Intravesical Docetaxel in the Management of Non–muscle-invasive Bladder Cancer Refractory to Standard Intravesical Therapy(2009)66 cited
- → The novel use of intravesical docetaxel for the treatment of non-muscle invasive bladder cancer refractory to BCG therapy: a single institution experience(2009)44 cited
- → A single‐institution experience with induction and maintenance intravesical docetaxel in the management of non‐muscle‐invasive bladder cancer refractory to bacille Calmette‐Guérin therapy(2009)43 cited